Founded in 1999, PELVIPHARM is a contract research organization (CRO) relying on multi-disciplinary talents (medical doctor, pharmaco-economist, veterinarian, pharmacists and PhDs) who deliver both high quality academic standards and reliable contract research services :
- Preclinical studies based on validated efficacy models including delivery of protocol development, study conduct, report, communication and peer-reviewed publication
- Guidance for selection of new chemical entities including testing with targeted assays according to potential mechanisms of action
- Identification of new properties or attributes supporting differentiation of medications within the class or between classes
- Advice in clinical development for new therapeutic indications or enhancements to address unmet medical need or significant commercial opportunities
PELVIPHARM has leading scientific and medical capabilities from unique expertise and experience in pathophysiology, pharmacology, clinical research and medical practice across a range of therapeutic areas including urology (BPH, OAB, NDO, SCI, SUI, IC …), sexual medicine (ED, PE, FSD …) and cardiovascular (Hypertension, Atherosclerosis, Myocardial Infarction …), metabolism and eating disorders (Metabolic Syndrome, Obesity, Diabetes ...)

PELVIPHARM provides customized services to clients according to their outsourcing needs, using experimental models based on the most recent exploration methods.
PELVIPHARM can give you the unique expertise and the experience of a team gathered over the years.
News and next meetings
AUA (American Urological Association) in Atlanta, GA, USA, 19 -23 may 2012. François Giuliano wil......
Recently published paper in Archives of Sexual Behavior
Who, What, Where, When (and Maybe Even Why)? How the Experience of Sexual Reward Connects Sexual Des......
Bio-Europe Spring in Amsterdam, March 2012
Pelvipharm will be represented by Delphine Behr-Roussel at the next BIO-Europe Spring meeting in Ams......
Recently published paper in Eur Urol
Minimal Effective Dose of Dysport and Botox in a Rat Model of Neurogenic Detrusor Overactivity. Beh......
Latest website updates
New abstract/poster available for download
presented at the EAU 2012 in Paris, France, 24-28 february, 20112
New experimental skills developed
Vaginal atrophy : blood flow engorgement measurment by Laser Doppler Flowmetry (rat/guinea pig/rabbit)
New model developped



To schedule a meeting, please contact us